Three targets in 1 shot against ibrutinib resistance

Abstract

In this issue of Blood, Dobrovolsky et al describe the in vitro and in vivo efficacy of a novel small molecule that induces the selective degradation of Bruton tyrosine kinase (BTK), IKZF1, and IKZF3, 3 proteins critical for the survival of many B-cell malignancies.1